logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 8 of 8 Items
Showing 1 - 8 of 8 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Review

Innovations in research ethics governance in humanitarian settings

Schopper D, Dawson A, Upshur R, Ahmad ASI, Jesani A,  et al.
2015-02-26 • BMC Medical Ethics
2015-02-26 • BMC Medical Ethics
BACKGROUND
Médecins Sans Frontières (MSF) is one of the world’s leading humanitarian medical organizations. The increased emphasis in MSF on research led to the creation of an ethics...
Journal Article
|
Commentary

Research ethics governance in times of Ebola

Schopper D, Ravinetto R, Schwartz L, Kamaara E, Sheel S,  et al.
2016-11-01 • Public Health Ethics
2016-11-01 • Public Health Ethics
The Médecins Sans Frontières (MSF) ethics review board (ERB) has been solicited in an unprecedented way to provide advice and review research protocols in an 'emergency' mode during the ...
Journal Article
|
Research

Evaluation of convalescent plasma for Ebola Virus Disease in Guinea

van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P,  et al.
2016-01-07 • New England Journal of Medicine
2016-01-07 • New England Journal of Medicine
BACKGROUND
In the wake of the recent outbreak of Ebola virus disease (EVD) in several African countries, the World Health Organization prioritized the evaluation of treatment with co...
Journal Article
|
Research

Exploring global and country-level barriers to an effective supply of leishmaniasis medicines and diagnostics in eastern Africa: a qualitative study

Sunyoto T, Potet J, den Boer ML, Ritmeijer KKD, Postigo JAR,  et al.
2019-05-01 • BMJ Open
2019-05-01 • BMJ Open
OBJECTIVES:
To understand stakeholders' perceptions of the access barriers to quality-assured diagnostics and medicines for leishmaniasis in the high-burden region of eastern Africa...
Journal Article
|
Commentary

Access to health care for undocumented migrants in Italy

Ravinetto R, Lodesani C, D'Alessandro U, De Filippi L, Pontiroli A
2009-06-20 • Lancet
2009-06-20 • Lancet
Journal Article
|
Research

Long-term Clinical Outcomes in Visceral Leishmaniasis-HIV Co-infected Patients during and after Pentamidine Secondary Prophylaxis in Ethiopia: a single-arm clinical trial

Diro EGJ, Ritmeijer KKD, Boelaert M, Alves F, Mohammed R,  et al.
2017-09-13 • Clinical Infectious Diseases
2017-09-13 • Clinical Infectious Diseases
We have conducted a single-arm trial evaluating monthly pentamidine secondary prophylaxis (PSP) to prevent visceral leishmaniasis (VL) relapse in Ethiopian HIV-patients. Outcomes at 12 m...
Journal Article
|
Review

Clinical Research in Neglected Tropical Diseases: The Challenge of Implementing Good Clinical (Laboratory) Practices

Ravinetto R, Alirol E, Mahendradhata Y, Rijal S, Lutumba P,  et al.
2016-11-03 • PLOS Neglected Tropical Diseases
2016-11-03 • PLOS Neglected Tropical Diseases
Journal Article
|
Commentary

Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy

Ravinetto R, Vandenbergh D, Macé C, Pouget C, Renchon B,  et al.
2016-11-10 • Journal of Pharmaceutical Policy and Practice
2016-11-10 • Journal of Pharmaceutical Policy and Practice
The globalization of pharmaceutical production has not been accompanied by a strengthening and harmonization of the regulatory systems worldwide. Thus, the global market is characterized...